Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2025-12-24 @ 4:12 PM
NCT ID:
NCT04020666
Eligibility Criteria:
Inclusion Criteria:
* Aged 18-75 years (male or female)
* Patients were admitted to hospital within 72h of stroke onset
* Diagnosis of acute ischemic stroke according to the criteria stated in the Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke in China (2010), and patients were confirmed as acute ischemic cerebrovascular disease by head computed tomography (CT) or magnetic resonance imaging (MRI) and diffusion weighted imaging (DWI)
* NIHSS score ranged from 3-21 points
* Patients were previously diagnosed with type 2 diabetes, in which they were in line with the 2006 WHO diagnostic criteria for diabetes, or they had fasting blood glucose of 6.1-6.9mmol/L and glycosylated hemoglobin (HbA1C) of\>6.1%
* Patients could cooperate with the test and evaluation of relevant indicators in the trial.
Exclusion criteria:
* Pregnant or lactating women
* Patients with severe heart, liver and kidney dysfunction
* Patients with a history of cerebrovascular disease and who still suffered from serious neurological dysfunction that had an influence on the trial
* Patients with physical disabilities, joint deformities or muscle lesions
* Patients were confirmed with intracranial hemorrhage by CT
* Patients were allergic to the study drug
* Patients suffering from severe systemic infection
* Patients who had participated in other clinical trials within 1 month
* For any reason, the researchers believed that the subject was unlikely to complete the study (such as cerebral infarction caused by cerebral embolism, intracranial arteritis, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and moyamoya disease; patients undergoing thrombolysis or thrombectomy after admission; patients and their families were unable to cooperate with follow-up.)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04020666
Study Brief:
Protocol Section:
NCT04020666